| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BOLD | Boundless Bio, Inc. | GILLIS STEVEN | 10% Owner | Apr 02, 2024 | Buy | $16.00 | 200,000 | 3,200,000 | 1,181,766 | Apr 04, 2024, 04:30 PM | |
| PRME | Prime Medicine, Inc. | GILLIS STEVEN | 10% Owner | Feb 15, 2024 | Buy | $6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20, 2024, 05:37 PM | |
| SANA | Sana Biotechnology, Inc. | GILLIS STEVEN | 10% Owner | Feb 08, 2024 | Buy | $5.50 | 1,818,181 | 9,999,996 | 12,446,022 | Feb 12, 2024, 05:43 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 13, 2023 | Buy | $11.75 | 31,653 | 371,923 | 4,127,850 | Nov 15, 2023, 06:54 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 14, 2023 | Buy | $11.98 | 3,357 | 40,217 | 4,131,207 | Nov 15, 2023, 06:54 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 08, 2023 | Buy | $11.03 | 92,251 | 1,017,821 | 4,047,843 | Nov 13, 2023, 07:00 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 09, 2023 | Buy | $10.53 | 31,079 | 327,262 | 4,078,922 | Nov 13, 2023, 07:00 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 10, 2023 | Buy | $11.49 | 17,275 | 198,481 | 4,096,197 | Nov 13, 2023, 07:00 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 07, 2023 | Buy | $11.50 | 30,192 | 347,208 | 3,955,592 | Nov 07, 2023, 06:59 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 03, 2023 | Buy | $11.38 | 22,420 | 255,140 | 3,882,318 | Nov 07, 2023, 06:59 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Nov 06, 2023 | Buy | $11.55 | 43,082 | 497,597 | 3,925,400 | Nov 07, 2023, 06:59 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Sep 28, 2023 | Buy | $13.44 | 41,951 | 563,699 | 3,825,338 | Sep 29, 2023, 06:53 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Sep 29, 2023 | Buy | $13.98 | 34,560 | 483,149 | 3,859,898 | Sep 29, 2023, 06:53 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Sep 27, 2023 | Buy | $12.31 | 24,504 | 301,644 | 3,783,387 | Sep 27, 2023, 08:18 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Sep 26, 2023 | Buy | $11.73 | 34,000 | 398,820 | 3,758,883 | Sep 27, 2023, 08:18 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Sep 22, 2023 | Buy | $11.14 | 40,000 | 445,600 | 3,664,143 | Sep 25, 2023, 09:38 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Sep 25, 2023 | Buy | $11.22 | 60,740 | 681,464 | 3,724,883 | Sep 25, 2023, 09:38 PM | |
| NMRA | Neumora Therapeutics, Inc. | GILLIS STEVEN | 10% Owner | Sep 19, 2023 | Buy | $17.00 | 1,500,000 | 25,500,000 | 3,624,143 | Sep 20, 2023, 06:16 AM | |
| VBIV | VBI Vaccines Inc/BC | GILLIS STEVEN | Director | Jul 10, 2023 | Buy | $1.65 | 609,090 | 1,004,998 | 1,043,292 | Jul 18, 2023, 09:00 AM | |
| PRME | Prime Medicine, Inc. | GILLIS STEVEN | 10% Owner | Oct 24, 2022 | Buy | $17.00 | 400,000 | 6,800,000 | 6,128,297 | Oct 26, 2022, 08:01 PM | |
| PRME | Prime Medicine, Inc. | GILLIS STEVEN | 10% Owner | Oct 24, 2022 | Buy | $17.00 | 400,000 | 6,800,000 | 6,128,297 | Oct 26, 2022, 08:01 PM | |
| DALS | DA32 Life Science Tech Acquisition Corp. | GILLIS STEVEN | 10% Owner | Jul 30, 2021 | Buy | $10.00 | 1,600,000 | 16,000,000 | 1,600,000 | Aug 03, 2021, 09:06 PM | |
| DALS | DA32 Life Science Tech Acquisition Corp. | GILLIS STEVEN | 10% Owner | Jul 30, 2021 | Option Exercise | $10.00 | 650,000 | 6,500,000 | 2,250,000 | Aug 03, 2021, 09:06 PM | |
| CDAK | Codiak BioSciences, Inc. | GILLIS STEVEN | Director | Oct 16, 2020 | Buy | $15.00 | 235,000 | 3,525,000 | 2,503,903 | Oct 20, 2020, 08:03 PM | |
| VBIV | VBI VACCINES INC. | GILLIS STEVEN | Director | Sep 19, 2019 | Buy | $0.50 | 10,000,000 | 5,000,000 | 13,026,057 | Sep 23, 2019, 08:48 PM | |
| SNNA | Sienna Biopharmaceuticals, Inc. | GILLIS STEVEN | 10% Owner | Feb 22, 2019 | Buy | $2.50 | 2,165,800 | 5,414,500 | 2,900,575 | Feb 26, 2019, 09:08 PM | |
| VBIV | VBI Vaccines Inc/BC | GILLIS STEVEN | Director | Oct 30, 2017 | Buy | $3.05 | 300,000 | 915,000 | 3,026,057 | Oct 31, 2017, 08:07 PM | |
| VBIV | VBI Vaccines Inc/BC | GILLIS STEVEN | Director | Jan 17, 2017 | Option Exercise | $2.50 | 6,377 | 15,943 | 28,166 | Mar 31, 2017, 08:20 PM | |
| PZRX | PHASERX, INC. | GILLIS STEVEN | Director | May 23, 2016 | Buy | $5.00 | 1,000,000 | 5,000,000 | 2,854,222 | May 25, 2016, 05:44 PM | |
| PZRX | PHASERX, INC. | GILLIS STEVEN | Director | May 23, 2016 | Sale | $0.01000 | 680,059 | 6,801 | 2,049,378 | May 25, 2016, 05:44 PM | |
| VBIV | VBI VACCINES INC. | GILLIS STEVEN | Director | Aug 13, 2015 | Option Exercise | $2.10 | 650,000 | 1,365,000 | 4,047,830 | Aug 17, 2015, 08:01 PM | |
| PULM | Pulmatrix, Inc. | GILLIS STEVEN | Director | Jun 16, 2015 | Buy | $6.88 | 72,750 | 500,156 | 2,286,456 | Jun 17, 2015, 08:29 PM | |
| BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Oct 09, 2014 | Sale | $35.25 | 115,000 | 4,053,888 | 1,041,111 | Oct 14, 2014, 05:07 PM | |
| BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Oct 03, 2014 | Sale | $35.74 | 26,635 | 951,935 | 1,186,911 | Oct 07, 2014, 05:34 PM | |
| BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Oct 06, 2014 | Sale | $35.16 | 24,100 | 847,356 | 1,162,811 | Oct 07, 2014, 05:34 PM | |
| BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Oct 07, 2014 | Sale | $35.15 | 6,700 | 235,505 | 1,156,111 | Oct 07, 2014, 05:34 PM | |
| BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Sep 30, 2014 | Sale | $36.08 | 32,095 | 1,157,988 | 1,272,616 | Oct 02, 2014, 05:43 PM | |
| BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Oct 01, 2014 | Sale | $34.75 | 11,516 | 400,181 | 1,261,100 | Oct 02, 2014, 05:43 PM | |
| BLUE | bluebird bio, Inc. | GILLIS STEVEN | Director | Oct 02, 2014 | Sale | $34.87 | 47,554 | 1,658,208 | 1,213,546 | Oct 02, 2014, 05:43 PM |
Menu